Non-Invasive Device for Early Detection Of Alzheimer’s
Delays in Development Put Clinical Trials Milestone at Risk
Non-Invasive Alzheimer’s Detection: Full SDLC Support for Developing Advanced Alzheimer’s Diagnostic System
The unique combination of MedAcuity’s technical expertise in design and implementation of complex software for embedded systems and understanding of workflow ensured client’s new device was ready for clinical trial submission.
project snapshot
SITUATION
- A small startup company is working on developing an innovative non invasive laser scanning device aimed at the early detection and diagnosis of Alzheimer’s disease.
- Developing a camera like device to produce high quality images capable of detecting the amount of beta-amyloid in a patient’s eye
Challenges
- Lack of proven expertise internally in developing complex software that is safe, secure and reliable while also meeting stringent FDA regulations
- Identify the root causes contributing to poor image quality and uncover required features to improve image quality
SOLUTION
- Comprehensive experiments on various camera features resulted in implementing new brightness and contrast features to the device’s settings library
- MedAcuity engineers completed hazard analysis, refined architecture and design, performed software implementation and system verification
Results
- MedTech company went to clinical trials and collected usable images on which to conduct scans
- From the scans, data could be collected and analyzed in order to detect the beta-amyloid measurements in patients who have signs and symptoms consistent with Alzheimer’s disease
- To date, the beginning stages of the project have been successful, and development is ongoing to further improve the promise of this new device for the early detection of Alzheimer’s
Explore some of our recent projects to learn how MedAcuity can accelerate your product development efforts.